tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ACET Stock Latest News

Adicet Bio’s Promising Developments and Strategic Advancements Justify Buy Rating
RatingsAdicet Bio’s Promising Developments and Strategic Advancements Justify Buy Rating
2M ago
ACET
Adicet Bio: Strategic Advancements and Financial Prudence Drive Buy Rating
PremiumRatings
Adicet Bio: Strategic Advancements and Financial Prudence Drive Buy Rating
2M ago
ACET
Adicet Bio Reports Q2 2025 Financial Results
PremiumCompany Announcements
Adicet Bio Reports Q2 2025 Financial Results
2M ago
ACET
Adicet Bio reports Q2 EPS (34c), consensus (30c)
PremiumThe Fly
Adicet Bio reports Q2 EPS (34c), consensus (30c)
2M ago
ACET
Promising Pipeline and FDA Fast Track Designations Justify Buy Rating for Adicet Bio
PremiumRatings
Promising Pipeline and FDA Fast Track Designations Justify Buy Rating for Adicet Bio
2M ago
ACET
Adicet Bio doses first patient in second cohort of ADI-001 trial
PremiumThe FlyAdicet Bio doses first patient in second cohort of ADI-001 trial
2M ago
ACET
Adicet Bio Announces 30% Workforce Reduction Strategy
Premium
Company Announcements
Adicet Bio Announces 30% Workforce Reduction Strategy
2M ago
8K
ACET
Adicet Bio assumed with a Buy at H.C. Wainwright
Premium
The Fly
Adicet Bio assumed with a Buy at H.C. Wainwright
2M ago
ACET
Adicet Bio Elects Directors and Approves Key Proposals
PremiumCompany Announcements
Adicet Bio Elects Directors and Approves Key Proposals
4M ago
8K
ACET
Adicet Bio’s Innovative Approach and Strong Financial Position Drive Buy Rating
PremiumRatings
Adicet Bio’s Innovative Approach and Strong Financial Position Drive Buy Rating
4M ago
ACET
Adicet Bio participates in a conference call with Truist
PremiumThe Fly
Adicet Bio participates in a conference call with Truist
5M ago
ACET
Adicet Bio’s Innovative Cell Therapy Programs and Strategic Focus Highlight Promising Growth Potential
PremiumRatings
Adicet Bio’s Innovative Cell Therapy Programs and Strategic Focus Highlight Promising Growth Potential
5M ago
ACET
Adicet Bio’s Promising Pipeline and Strategic Developments Earn Buy Rating
PremiumRatingsAdicet Bio’s Promising Pipeline and Strategic Developments Earn Buy Rating
5M ago
ACET
Adicet Bio Reports Q1 2025 Results and Updates
Premium
Company Announcements
Adicet Bio Reports Q1 2025 Results and Updates
5M ago
ACET
Adicet Bio reports Q1 EPS (31c), consensus (34c)
Premium
The Fly
Adicet Bio reports Q1 EPS (31c), consensus (34c)
5M ago
ACET
Adicet Bio Appoints Michael Grissinger to Board
PremiumCompany Announcements
Adicet Bio Appoints Michael Grissinger to Board
5M ago
8K
ACET
Adicet Bio’s ADI-001: A Promising Off-the-Shelf Therapy with Positive Outlook
PremiumRatings
Adicet Bio’s ADI-001: A Promising Off-the-Shelf Therapy with Positive Outlook
6M ago
ACET
Adicet Bio’s Innovative CAR γδ T Cell Therapies: A Promising Buy Rating Amidst Upcoming Phase 1 Data and Market Positioning
PremiumRatings
Adicet Bio’s Innovative CAR γδ T Cell Therapies: A Promising Buy Rating Amidst Upcoming Phase 1 Data and Market Positioning
6M ago
ACET
Buy Recommendation for Adicet Bio’s ADI-001: Promising Potential in Autoimmune Disease Treatment
PremiumRatings
Buy Recommendation for Adicet Bio’s ADI-001: Promising Potential in Autoimmune Disease Treatment
7M ago
ACET
Promising Pipeline and Strong Financials Drive Buy Rating for Adicet Bio
PremiumRatingsPromising Pipeline and Strong Financials Drive Buy Rating for Adicet Bio
7M ago
ACET
Adicet Bio Advances Clinical Trials and Financial Stability
Premium
Company Announcements
Adicet Bio Advances Clinical Trials and Financial Stability
7M ago
ACET
Cautious Hold Rating on Adicet Bio Amid Early-Stage Clinical Developments and Uncertain Outcomes
Premium
Ratings
Cautious Hold Rating on Adicet Bio Amid Early-Stage Clinical Developments and Uncertain Outcomes
7M ago
ACET

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >